Medical Cannabis Market Segmentation by Derivative: Cannabidiol, Tetrahydrocannabinol, and Others; Application: Mental Health Management, Neurological Disorders Management, and Pain Management; Route of Administration: Nasal, Oral, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, and Forecast, 2019-2027
Sr. No. Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 Chapter 12 Chapter 13 Chapter 14 Chapter 15 Content Preface Assumptions and Research Methodology Market Overview Market Dynamics Global Medical Cannabis Market Analysis and Forecasts, By Software Type Global Medical Cannabis Market Analysis, by Modality Global Medical Cannabis Market Analysis, by Application Global Medical Cannabis Market Analysis, by End-user Global Medical Cannabis Market Analysis and Forecast by Region North America Medical Cannabis Market Analysis and Forecast Europe Medical Cannabis Market Analysis and Forecast Asia Pacific Medical Cannabis Market Analysis and Forecast Latin America Medical Cannabis Market Analysis and Forecast Middle East & Africa Medical Cannabis Market Analysis and Forecast Competition Landscape
According to the latest report published by Transparency Market Research on the global medical cannabis market for the historical period 2017 2018 and forecast period from 2019 to 2027. Higher demand for pain management products is projected to be a major driver of the global medical cannabis market during the forecast period The benefit of medical cannabis is that it complements the normal cannabis system called the endocannabinoid system in the body. Interest in and usage of medical cannabis is increasing significantly in several countries.
The global medical cannabis market was valued at US$ 8 Bn in 2018 and is anticipated to expand at a CAGR of ~27% from 2019 to 2027 Regulations governing its usage differ across countries and influence medical practice and experience. The current opinion among the public is that medical cannabis has the therapeutic potential to prevent and treat a long list of disorders. Cannabis therapy provides the geriatric population with relief from symptoms such as vomiting, sleep difficulties, chronic pain, tremor, agitation, spasticity, nausea, and decreased appetite.
Product invention and advancements in cannabis varieties, infused products, concentrates, vaporizing technology, and cannabis-based pharmaceutical products are projected to drive consumer adoption and spending. Medical cannabis consumer product companies will seek to differentiate their products through marketing, pricing, packaging, distribution, selection, and quality. In terms of derivative, the global medical cannabis market has been classified into cannabidiol (CBD), tetrahydrocannabinol (THC), and others.
The global medical cannabis market is highly fragmented, with a large number of players holding majority share in domestic markets. Development and commercialization of medical cannabis products is one of the key trends in the global medical cannabis market. Prominent players operating in the global medical cannabis market include Canopy Growth Corp., United Cannabis, Aurora Cannabis, Cannabis Sativa, Inc., Emerald Health Therapeutics, GW Pharmaceuticals plc, Tilray, Medical Marijuana, Inc., The Supreme Cannabis Company, Inc., and The Cronos Group.
To know more about us, please visit our website www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com Thank You